bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Table from Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
Authors: Verset Gontran , Borbath Ivan , Karwal Mark , Verslype Chris , Van Vlierberghe Hans , Kardosh Adel , Zagonel Vittorina , Stal Per , Sarker Debashis , Palmer Daniel H. , Vogel Arndt , Edeline Julien , Cattan Stephane , Kudo Masatoshi , Cheng Ann-Lii , Ogasawara Sadahisa , Daniele Bruno , Chan Stephen L. , Knox Jennifer J. , Qin Shukui , Siegel Abby B. , Chisamore Michael , Hatogai Ken , Wang Anran , Finn Richard S. , Zhu Andrew X.
Published: April 2023

Supplementary Table from Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
Supplementary Figure from Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
Authors: Verset Gontran , Borbath Ivan , Karwal Mark , Verslype Chris , Van Vlierberghe Hans , Kardosh Adel , Zagonel Vittorina , Stal Per , Sarker Debashis , Palmer Daniel H. , Vogel Arndt , Edeline Julien , Cattan Stephane , Kudo Masatoshi , Cheng Ann-Lii , Ogasawara Sadahisa , Daniele Bruno , Chan Stephen L. , Knox Jennifer J. , Qin Shukui , Siegel Abby B. , Chisamore Michael , Hatogai Ken , Wang Anran , Finn Richard S. , Zhu Andrew X.
Published: April 2023

Supplementary Figure from Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
Supplementary Figure from Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
Authors: Zhang Mingzhi , Chen Dan , Fu Xiaorui , Meng Huimin , Nan Feifei , Sun Zhenchang , Yu Hui , Zhang Lei , Li Ling , Li Xin , Wang Xinhua , Wang Min , You Fengtao , Li Zhaoming , Chang Yu , Zhou Zhiyuan , Yan Jiaqin , Li Jiwei , Wu Xiaolong , Wang Yu , Wang Yinyan , Xiang Shufen , Chen YuSheng , Pan Guifang , Xu Hanying , Zhang Bozhen , Yang Lin
Published: April 2023

Supplementary Figure from Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
Supplementary Data from Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
Authors: Verset Gontran , Borbath Ivan , Karwal Mark , Verslype Chris , Van Vlierberghe Hans , Kardosh Adel , Zagonel Vittorina , Stal Per , Sarker Debashis , Palmer Daniel H. , Vogel Arndt , Edeline Julien , Cattan Stephane , Kudo Masatoshi , Cheng Ann-Lii , Ogasawara Sadahisa , Daniele Bruno , Chan Stephen L. , Knox Jennifer J. , Qin Shukui , Siegel Abby B. , Chisamore Michael , Hatogai Ken , Wang Anran , Finn Richard S. , Zhu Andrew X.
Published: April 2023

Supplementary Data from Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
Supplementary Data from Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia
Authors: Baer Maria R. , Kogan Aksinija A. , Bentzen Søren M. , Mi Tian , Lapidus Rena G. , Duong Vu H. , Emadi Ashkan , Niyongere Sandrine , O'Connell Casey L. , Youngblood Benjamin A. , Baylin Stephen B. , Rassool Feyruz V.
Published: April 2023

Supplementary Data from Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia
Supplementary Data from Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
Authors: Martin John D. , Lanning Ryan M. , Chauhan Vikash P. , Martin Margaret R. , Mousa Ahmed S. , Kamoun Walid S. , Han Hee-Sun , Lee Hang , Stylianopoulos Triantafyllos , Bawendi Moungi G. , Duda Dan G. , Brown Edward B. , Padera Timothy P. , Fukumura Dai , Jain Rakesh K.
Published: April 2023

Supplementary Data from Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
Supplementary Table S1 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
Authors: Obradovic Aleksandar , Graves Diana , Korrer Michael , Wang Yu , Roy Sohini , Naveed Abdullah , Xu Yaomin , Luginbuhl Adam , Curry Joseph , Gibson Michael , Idrees Kamran , Hurley Paula , Jiang Peng , Liu X. Shirley , Uppaluri Ravindra , Drake Charles G. , Califano Andrea , Kim Young J.
Published: April 2023

Supplementary Table S1 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
Supplementary Figure S7 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
Authors: Obradovic Aleksandar , Graves Diana , Korrer Michael , Wang Yu , Roy Sohini , Naveed Abdullah , Xu Yaomin , Luginbuhl Adam , Curry Joseph , Gibson Michael , Idrees Kamran , Hurley Paula , Jiang Peng , Liu X. Shirley , Uppaluri Ravindra , Drake Charles G. , Califano Andrea , Kim Young J.
Published: April 2023

Supplementary Figure S7 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
Supplementary Data from Neoadjuvant Trastuzumab and Pyrotinib for Locally Advanced HER2-Positive Breast Cancer (NeoATP): Primary Analysis of a Phase II Study
Authors: Yin Wenjin , Wang Yaohui , Wu Ziping , Ye Yumei , Zhou Liheng , Xu Shuguang , Lin Yanping , Du Yueyao , Yan Tingting , Yang Fan , Zhang Jie , Liu Qiang , Lu Jinsong
Published: April 2023

Supplementary Data from Neoadjuvant Trastuzumab and Pyrotinib for Locally Advanced HER2-Positive Breast Cancer (NeoATP): Primary Analysis of a Phase II Study
Supplementary Figure S1 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
Authors: Obradovic Aleksandar , Graves Diana , Korrer Michael , Wang Yu , Roy Sohini , Naveed Abdullah , Xu Yaomin , Luginbuhl Adam , Curry Joseph , Gibson Michael , Idrees Kamran , Hurley Paula , Jiang Peng , Liu X. Shirley , Uppaluri Ravindra , Drake Charles G. , Califano Andrea , Kim Young J.
Published: April 2023

Supplementary Figure S1 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
Supplementary Data from Perioperative ctDNA-Based Molecular Residual Disease Detection for Non–Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1)
Authors: Xia Liang , Mei Jiandong , Kang Ran , Deng Senyi , Chen Yaohui , Yang Ying , Feng Gang , Deng Yulan , Gan Fanyi , Lin Yidan , Pu Qiang , Ma Lin , Lin Feng , Yuan Yong , Hu Yang , Guo Chenglin , Liao Hu , Liu Chengwu , Zhu Yunke , Wang Wenping , Liu Zheng , Xu Yuyang , Li Kaidi , Li Chuan , Li Qingyun , He Ji , Chen Weizhi , Zhang Xiaolong , Kou Yingli , Wang Yun , Wu Zhu , Che Guowei , Chen Longqi , Liu Lunxu
Published: April 2023

Supplementary Data from Perioperative ctDNA-Based Molecular Residual Disease Detection for Non–Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1)
Supplementary Data from Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data
Authors: Fisher Natalie C. , Byrne Ryan M. , Leslie Holly , Wood Colin , Legrini Assya , Cameron Andrew J. , Ahmaderaghi Baharak , Corry Shania M. , Malla Sudhir B. , Amirkhah Raheleh , McCooey Aoife J. , Rogan Emily , Redmond Keara L. , Sakhnevych Svetlana , Domingo Enric , Jackson James , Loughrey Maurice B. , Leedham Simon , Maughan Tim , Lawler Mark , Sansom Owen J. , Lamrock Felicity , Koelzer Viktor H. , Jamieson Nigel B. , Dunne Philip D.
Published: April 2023

Supplementary Data from Biological Misinterpretation of Transcriptional Signatures in Tumor Samples Can Unknowingly Undermine Mechanistic Understanding and Faithful Alignment with Preclinical Data
Supplementary Table from Neoantigen Identification and Response to Adoptive Cell Transfer in Anti–PD-1 Naïve and Experienced Patients with Metastatic Melanoma
Authors: Levi Shoshana T. , Copeland Amy R. , Nah Shirley , Crystal Jessica S. , Ivey Gabriel D. , Lalani Almin , Jafferji Mohammad , White Bradley S. , Parikh Neilesh B. , Leko Vid , Krishna Sri , Lowery Frank , Prickett Todd D. , Gartner Jared J. , Jia Li , Li Yong F. , Sachs Abraham , Sindiri Sivasish , Robinson Welles , Gasmi Billel , Yang James C. , Goff Stephanie L. , Rosenberg Steven A. , Robbins Paul F.
Published: April 2023

Supplementary Table from Neoantigen Identification and Response to Adoptive Cell Transfer in Anti–PD-1 Naïve and Experienced Patients with Metastatic Melanoma
Supplementary Figure from Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors
Authors: Munster Pamela N. , Greenstein Andrew E. , Fleming Gini F. , Borazanci Erkut , Sharma Manish R. , Custodio Joseph M. , Tudor Iulia Cristina , Pashova Hristina I. , Shepherd Stacie Peacock , Grauer Andreas , Sachdev Jasgit C.
Published: April 2023

Supplementary Figure from Overcoming Taxane Resistance: Preclinical and Phase 1 Studies of Relacorilant, a Selective Glucocorticoid Receptor Modulator, with Nab-Paclitaxel in Solid Tumors
Supplementary Figure 2 from Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience
Authors: Marmouset Vincent , Decroocq Justine , Garciaz Sylvain , Etienne Gabriel , Belhabri Amine , Bertoli Sarah , Gastaud Lauris , Simand Célestine , Chantepie Sylvain , Uzunov Madalina , Genthon Alexis , Berthon Céline , Chiche Edmond , Dumas Pierre-Yves , Vargaftig Jacques , Salmeron Géraldine , Lemasle Emilie , Tavernier Emmanuelle , Delage Jérémy , Loirat Marion , Morineau Nadine , Blanc-Durand Félix , Pautier Patricia , Vergé Véronique , Auger Nathalie , Thomas Myrtille , Stefani Laetitia , Lepelley Marion , Boyer Thomas , Thepot Sylvain , Gourin Marie-Pierre , Bourquard Pascal , Duchmann Matthieu , Morice Pierre-Marie , Michallet Mauricette , Adès Lionel , Fenaux Pierre , Récher Christian , Dombret Hervé , Pagès Arnaud , Marzac Christophe , Leary Alexandra , Micol Jean-Baptiste
Published: April 2023

Blood smear and bone marrow aspiration of patient referred for cytopenia post PARPi.
Supplementary Figure 1 from Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience
Authors: Marmouset Vincent , Decroocq Justine , Garciaz Sylvain , Etienne Gabriel , Belhabri Amine , Bertoli Sarah , Gastaud Lauris , Simand Célestine , Chantepie Sylvain , Uzunov Madalina , Genthon Alexis , Berthon Céline , Chiche Edmond , Dumas Pierre-Yves , Vargaftig Jacques , Salmeron Géraldine , Lemasle Emilie , Tavernier Emmanuelle , Delage Jérémy , Loirat Marion , Morineau Nadine , Blanc-Durand Félix , Pautier Patricia , Vergé Véronique , Auger Nathalie , Thomas Myrtille , Stefani Laetitia , Lepelley Marion , Boyer Thomas , Thepot Sylvain , Gourin Marie-Pierre , Bourquard Pascal , Duchmann Matthieu , Morice Pierre-Marie , Michallet Mauricette , Adès Lionel , Fenaux Pierre , Récher Christian , Dombret Hervé , Pagès Arnaud , Marzac Christophe , Leary Alexandra , Micol Jean-Baptiste
Published: April 2023

Flow chart of the study displaying the three cohorts.
Supplementary Data from Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers
Authors: Braman Nathaniel , Prasanna Prateek , Bera Kaustav , Alilou Mehdi , Khorrami Mohammadhadi , Leo Patrick , Etesami Maryam , Vulchi Manasa , Turk Paulette , Gupta Amit , Jain Prantesh , Fu Pingfu , Pennell Nathan , Velcheti Vamsidhar , Abraham Jame , Plecha Donna , Madabhushi Anant
Published: April 2023

Supplementary Data from Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers
Supplementary Figures S1-S4 from Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies
Authors: Tantawy Shady I. , Sarkar Aloke , Hubner Stefan , Tan Zhi , Wierda William G. , Eldeib Abdelraouf , Zhang Shuxing , Kornblau Steven , Gandhi Varsha
Published: April 2023

Supplemental Figure S1. Changes in protein expression levels induced by MCL-1 inhibitor. Supplemental Figure S2. Impact of MCL-1 inhibitors on total Mcl-1, T163 and S159 phosphorylation.Supplemental Figure S3. MCL-1 inhibitors induce a transient decrease in Mule.Supplemental Figure S4. In vitro De-ubiquitinating activity assay of USP9x with MCL-1 inhibitors.
Supplementary Data from A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial
Authors: Hillemanns Peter , Denecke Agnieszka , Woelber Linn , Böhmer Gerd , Jentschke Matthias , Schjetne Karoline W. , Bruins Slot Karsten M.H. , Fredriksen Agnete B.
Published: April 2023

Supplementary Data from A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial
Supplementary Figure from An Ex Vivo Organotypic Culture Platform for Functional Interrogation of Human Appendiceal Cancer Reveals a Prominent and Heterogenous Immunological Landscape
Authors: Weitz Jonathan , Hurtado de Mendoza Tatiana , Tiriac Herve , Lee James , Sun Siming , Garg Bharti , Patel Jay , Li Kevin , Baumgartner Joel , Kelly Kaitlin J. , Veerapong Jula , Hosseini Mojgan , Chen Yuan , Lowy Andrew M.
Published: April 2023

Supplementary Figure from An Ex Vivo Organotypic Culture Platform for Functional Interrogation of Human Appendiceal Cancer Reveals a Prominent and Heterogenous Immunological Landscape
Supplementary Appendix 1 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies
Authors: Zhai Yifan , Tang Qiuqiong , Fang Douglas D. , Deng Jing , Zhang Kaixiang , Wang Qixin , Yin Yan , Fu Chengcheng , Xue Sheng-Li , Li Na , Zhou Feng , Yang Dajun
Published: April 2023

Supplementary Figure and Table legends
Supplementary Data from An Ex Vivo Organotypic Culture Platform for Functional Interrogation of Human Appendiceal Cancer Reveals a Prominent and Heterogenous Immunological Landscape
Authors: Weitz Jonathan , Hurtado de Mendoza Tatiana , Tiriac Herve , Lee James , Sun Siming , Garg Bharti , Patel Jay , Li Kevin , Baumgartner Joel , Kelly Kaitlin J. , Veerapong Jula , Hosseini Mojgan , Chen Yuan , Lowy Andrew M.
Published: April 2023

Supplementary Data from An Ex Vivo Organotypic Culture Platform for Functional Interrogation of Human Appendiceal Cancer Reveals a Prominent and Heterogenous Immunological Landscape
Supplementary Appendix S1 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
Authors: Ligon John A. , Sundby R. Taylor , Wedekind Mary F. , Arnaldez Fernanda I. , Del Rivero Jaydira , Wiener Lori , Srinivasan Ramaprasad , Spencer Melissa , Carbonell Amanda , Lei Haiyan , Shern John , Steinberg Seth M. , Figg William D. , Peer Cody J. , Zimmerman Sara , Moraly Josquin , Xu Xia , Fox Stephen , Chan King , Barbato Michael I. , Andresson Thorkell , Taylor Naomi , Pacak Karel , Killian J. Keith , Dombi Eva , Linehan W. Marston , Miettinen Markku , Piekarz Richard , Helman Lee J. , Meltzer Paul , Widemann Brigitte , Glod John
Published: April 2023

Supplemental methods and figures
Table S1 from Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study
Authors: Wang-Gillam Andrea , Lim Kian-Huat , McWilliams Robert , Suresh Rama , Lockhart Albert C. , Brown Amberly , Breden Marcus , Belle Jad I. , Herndon John , Bogner Savannah J. , Pedersen Katrina , Tan Benjamin , Boice Nicholas , Acharya Abhi , Abdiannia Mina , Gao Feng , Yoon Harry H. , Zhu Mojun , Trikalinos Nikolaos A. , Ratner Lee , Aranha Olivia , Hawkins William G. , Herzog Brett H. , DeNardo David G.
Published: April 2023

Supplemental Table 1
Patient demographics
Supplementary Table S5 from Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation
Authors: Serra-Camprubí Queralt , Verdaguer Helena , Oliveros Winona , Lupión-Garcia Núria , Llop-Guevara Alba , Molina Cristina , Vila-Casadesús Maria , Turpin Anthony , Neuzillet Cindy , Frigola Joan , Querol Jessica , Yáñez-Bartolomé Mariana , Castet Florian , Fabregat-Franco Carles , Escudero-Iriarte Carmen , Escorihuela Marta , Arenas Enrique J. , Bernadó-Morales Cristina , Haro Noemí , Giles Francis J. , Pozo Óscar J. , Miquel Josep M. , Nuciforo Paolo G. , Vivancos Ana , Melé Marta , Serra Violeta , Arribas Joaquín , Tabernero Josep , Peiró Sandra , Macarulla Teresa , Tian Tian V.
Published: April 2023

Information of CCA patients from a different cohort.
Supplementary Figure from Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer
Authors: Zhu Zheng , Ma Ai-Hong , Zhang Hongyong , Lin Tzu-Yin , Xue Xiangdong , Farrukh Hizra , Zhu Shaoming , Shi Wei , Yuan Ruan , Cao Zhixiu , Chittepu Veera Chandra Sekhar Reddy , Prabhala Rao , Li Yuanpei , Lam Kit S. , Pan Chong-xian
Published: April 2023

Supplementary Figure from Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer
Supplementary Figure from EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma
Authors: Apfelbaum April A. , Wu Feinan , Hawkins Allegra G. , Magnuson Brian , Jiménez Jennifer A. , Taylor Sean D. , Wrenn Emma D. , Waltner Olivia , Pfaltzgraff Elise R. , Song Jane Y. , Hall Cody , Wellik Deneen M. , Ljungman Mats , Furlan Scott N. , Ryan Russell J.H. , Sarthy Jay F. , Lawlor Elizabeth R.
Published: April 2023

Supplementary Figure from EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma
Supplementary Methods 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma
Authors: Shoushtari Alexander N. , Olszanski Anthony J. , Nyakas Marta , Hornyak Thomas J. , Wolchok Jedd D. , Levitsky Victor , Kuryk Lukasz , Hansen Thomas B. , Jäderberg Magnus
Published: April 2023

Supplementary methods
Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma
Authors: Shoushtari Alexander N. , Olszanski Anthony J. , Nyakas Marta , Hornyak Thomas J. , Wolchok Jedd D. , Levitsky Victor , Kuryk Lukasz , Hansen Thomas B. , Jäderberg Magnus
Published: April 2023

Immunologic pathway genes
Supplementary Table S3 from A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck
Authors: Nathan Cherie-Ann O. , Hayes D. Neil , Karrison Theodore , Harismendy Olivier , Flores José M. , Moore-Medlin Tara , Vokes Everett E. , Gutkind J. Silvio , Neupane Prakash , Mills Glenn , Sargi Zoukaa , Seiwert Tanguy , Grilley-Olson Juneko , Day Terry , Gillison Maura , Wade James L. , Feldman Lawrence , Jha Gautam , Kozloff Mark , O'Leary Miriam , Worden Francis P. , Cohen Ezra E.W.
Published: April 2023

Adverse events at least possibly related to study drug by NIH-NCI Common Terminology Criteria for Adverse Events (CTCAE), version. 4.0.
Supplementary Table S2 from A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck
Authors: Nathan Cherie-Ann O. , Hayes D. Neil , Karrison Theodore , Harismendy Olivier , Flores José M. , Moore-Medlin Tara , Vokes Everett E. , Gutkind J. Silvio , Neupane Prakash , Mills Glenn , Sargi Zoukaa , Seiwert Tanguy , Grilley-Olson Juneko , Day Terry , Gillison Maura , Wade James L. , Feldman Lawrence , Jha Gautam , Kozloff Mark , O'Leary Miriam , Worden Francis P. , Cohen Ezra E.W.
Published: April 2023

TP53 wild-type and mutant patients received similar definitive treatment.
Supplementary Table S1 from A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck
Authors: Nathan Cherie-Ann O. , Hayes D. Neil , Karrison Theodore , Harismendy Olivier , Flores José M. , Moore-Medlin Tara , Vokes Everett E. , Gutkind J. Silvio , Neupane Prakash , Mills Glenn , Sargi Zoukaa , Seiwert Tanguy , Grilley-Olson Juneko , Day Terry , Gillison Maura , Wade James L. , Feldman Lawrence , Jha Gautam , Kozloff Mark , O'Leary Miriam , Worden Francis P. , Cohen Ezra E.W.
Published: April 2023

List of all observed somatic mutations in TP53.
Supplementary Data1 from Meta-Analysis of the Test–Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor Response
Authors: Shankar Lalitha K. , Huang Erich , Litiere Saskia , Hoekstra Otto S. , Schwartz Larry , Collette Sandra , Boellaard Ronald , Bogaerts Jan , Seymour Lesley , deVries Elisabeth G.E.
Published: April 2023

Statistical methodology
Supplementary Table S5 from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial
Authors: Basile Giuseppe , Bandini Marco , Gibb Ewan A. , Ross Jeffrey S. , Raggi Daniele , Marandino Laura , Costa de Padua Tiago , Crupi Emanuele , Colombo Renzo , Colecchia Maurizio , Lucianò Roberta , Nocera Luigi , Moschini Marco , Briganti Alberto , Montorsi Francesco , Necchi Andrea
Published: April 2023

Distribution of the GSC subtypes according to the Consensus Bladder Cancer classification.
Supplementary Tables S1-S5 from Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial
Authors: Gonzalez-Lugo Jesus D. , Kambhampati Suman , Yacoub Abdulraheem , Donnellan William B. , Berdeja Jesus , Bhagat Prafulla , Fehn Karen , Remy Cassady , Jasra Sakshi , Kazemi Mohammed , Pradhan Kith , Kim Mimi , Mantzaris Ioannis , Sica R. Alejandro , Shah Nishi , Goldfinger Mendel , Kornblum Noah , Gritsman Kira , Braunschweig Ira , Steidl Ulrich , Will Britta , Shastri Aditi , Verma Amit
Published: April 2023

Supplemental Table 1. MDS International Working Group response criteria for hematologic improvement
Supplemental Table 2. Differences in Baseline Patient Characteristics
Supplemental Table 3. Responses by Cytogenetics
Supplemental Table 4. Responses by Mutation
Supplemental Table 5. Study Representativeness Table
Supplementary Table S2 from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial
Authors: Basile Giuseppe , Bandini Marco , Gibb Ewan A. , Ross Jeffrey S. , Raggi Daniele , Marandino Laura , Costa de Padua Tiago , Crupi Emanuele , Colombo Renzo , Colecchia Maurizio , Lucianò Roberta , Nocera Luigi , Moschini Marco , Briganti Alberto , Montorsi Francesco , Necchi Andrea
Published: April 2023

Surgical safety outcomes in PURE-01 trial
Supplementary Table S1 from Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial
Authors: Basile Giuseppe , Bandini Marco , Gibb Ewan A. , Ross Jeffrey S. , Raggi Daniele , Marandino Laura , Costa de Padua Tiago , Crupi Emanuele , Colombo Renzo , Colecchia Maurizio , Lucianò Roberta , Nocera Luigi , Moschini Marco , Briganti Alberto , Montorsi Francesco , Necchi Andrea
Published: April 2023

Updated adverse events observed in ITT population
Supplementary Table from ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma
Authors: Mulgaonkar Aditi , Elias Roy , Woolford Layton , Guan Bing , Nham Kien , Kapur Payal , Christie Alana , Tcheuyap Vanina T. , Singla Nirmish , Bowman I. Alex , Stevens Christina , Hao Guiyang , Brugarolas James , Sun Xiankai
Published: April 2023

Supplementary Table from ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma
Supplementary Data from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer
Authors: Tsuji Junko , Li Tianyu , Grinshpun Albert , Coorens Tim , Russo Douglas , Anderson Leilani , Rees Rebecca , Nardone Agostina , Patterson Candace , Lennon Niall J. , Cibulskis Carrie , Leshchiner Ignaty , Tayob Nabihah , Tolaney Sara M. , Tung Nadine , McDonnell Donald P. , Krop Ian E. , Winer Eric P. , Stewart Chip , Getz Gad , Jeselsohn Rinath
Published: April 2023

supplemental tables 5-7
Supplemental Figure 6 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer
Authors: Tsuji Junko , Li Tianyu , Grinshpun Albert , Coorens Tim , Russo Douglas , Anderson Leilani , Rees Rebecca , Nardone Agostina , Patterson Candace , Lennon Niall J. , Cibulskis Carrie , Leshchiner Ignaty , Tayob Nabihah , Tolaney Sara M. , Tung Nadine , McDonnell Donald P. , Krop Ian E. , Winer Eric P. , Stewart Chip , Getz Gad , Jeselsohn Rinath
Published: April 2023

Supplemental Figure 6: Evolutionary analysis of longitudinal plasma ctDNA samples
Supplemental Figure 3 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer
Authors: Tsuji Junko , Li Tianyu , Grinshpun Albert , Coorens Tim , Russo Douglas , Anderson Leilani , Rees Rebecca , Nardone Agostina , Patterson Candace , Lennon Niall J. , Cibulskis Carrie , Leshchiner Ignaty , Tayob Nabihah , Tolaney Sara M. , Tung Nadine , McDonnell Donald P. , Krop Ian E. , Winer Eric P. , Stewart Chip , Getz Gad , Jeselsohn Rinath
Published: April 2023

Supplemental Figure 3: Plasma circulating tumor DNA (ctDNA) tumor fraction (TF)
dynamics determined with ULP-WGS
Supplemental Figure 2 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer
Authors: Tsuji Junko , Li Tianyu , Grinshpun Albert , Coorens Tim , Russo Douglas , Anderson Leilani , Rees Rebecca , Nardone Agostina , Patterson Candace , Lennon Niall J. , Cibulskis Carrie , Leshchiner Ignaty , Tayob Nabihah , Tolaney Sara M. , Tung Nadine , McDonnell Donald P. , Krop Ian E. , Winer Eric P. , Stewart Chip , Getz Gad , Jeselsohn Rinath
Published: April 2023

Supplemental Figure 2: Plasma circulating tumor DNA (ctDNA) collection and analysis
Supplementary Table from Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets
Authors: Kocher Florian , Puccini Alberto , Untergasser Gerold , Martowicz Agnieszka , Zimmer Kai , Pircher Andreas , Baca Yasmine , Xiu Joanne , Haybaeck Johannes , Tymoszuk Piotr , Goldberg Richard M. , Petrillo Angelica , Shields Anthony F. , Salem Mohamed E. , Marshall John L. , Hall Michael , Korn W. Michael , Nabhan Chadi , Battaglin Francesca , Lenz Heinz-Josef , Lou Emil , Choo Su-Pin , Toh Chee-Keong , Gasteiger Silvia , Pichler Renate , Wolf Dominik , Seeber Andreas
Published: April 2023

Supplementary Table from Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets
Supplemental Figure 1 from Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor–Positive Breast Cancer
Authors: Tsuji Junko , Li Tianyu , Grinshpun Albert , Coorens Tim , Russo Douglas , Anderson Leilani , Rees Rebecca , Nardone Agostina , Patterson Candace , Lennon Niall J. , Cibulskis Carrie , Leshchiner Ignaty , Tayob Nabihah , Tolaney Sara M. , Tung Nadine , McDonnell Donald P. , Krop Ian E. , Winer Eric P. , Stewart Chip , Getz Gad , Jeselsohn Rinath
Published: April 2023

Supplemental Figure 1: Consort diagram
Supplementary Data from Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study
Authors: Weber Manuel , Kersting David , Riemann Burkhard , Brandenburg Tim , Führer-Sakel Dagmar , Grünwald Frank , Kreissl Michael C. , Dralle Henning , Weber Frank , Schmid Kurt Werner , Herrmann Ken , Jentzen Walter , Grafe Hong , Rischpler Christoph , Theurer Sarah , Bockisch Andreas , Nagarajah James , Fendler Wolfgang P.
Published: April 2023

Supplementary Data from Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study
Supplementary Figures S1-S2 from hENT1 Expression Predicts Response to Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Ductal Adenocarcinoma
Authors: Perera Sheron , Jang Gun Ho , Wang Yifan , Kelly Deirdre , Allen Michael , Zhang Amy , Denroche Robert E. , Dodd Anna , Ramotar Stephanie , Hutchinson Shawn , Tehfe Mustapha , Ramjeesingh Ravi , Biagi James , Lam Bernard , Wilson Julie , Fischer Sandra E. , Zogopoulos George , Notta Faiyaz , Gallinger Steven , Grant Robert C. , Knox Jennifer J. , O'Kane Grainne M.
Published: April 2023

Figure S1. hENT1 expression by modified Moffitt subtypes
Figure S2. OS in GnP cohort stratified by hENT1 and modified Moffitt Classifier
Supplementary Table S4 from Necroptosis-dependent Immunogenicity of Cisplatin: Implications for Enhancing the Radiation-induced Abscopal Effect
Authors: Luo Ren , Onyshchenko Kateryna , Wang Liqun , Gaedicke Simone , Grosu Anca-Ligia , Firat Elke , Niedermann Gabriele
Published: April 2023

ICB trials analyzed in Figure 6C and D.
Supplementary Table S1 from Necroptosis-dependent Immunogenicity of Cisplatin: Implications for Enhancing the Radiation-induced Abscopal Effect
Authors: Luo Ren , Onyshchenko Kateryna , Wang Liqun , Gaedicke Simone , Grosu Anca-Ligia , Firat Elke , Niedermann Gabriele
Published: April 2023

IC50 of platinum derivatives for B16-CD133 and C51 tumor cells.
Supplementary Data from Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years
Authors: Plym Anna , Zhang Yiwen , Stopsack Konrad H. , Jee Yon Ho , Wiklund Fredrik , Kibel Adam S. , Kraft Peter , Giovannucci Edward , Penney Kathryn L. , Mucci Lorelei A.
Published: April 2023

Supplementary Data from Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years
Supplementary Figure S9 from Necroptosis-dependent Immunogenicity of Cisplatin: Implications for Enhancing the Radiation-induced Abscopal Effect
Authors: Luo Ren , Onyshchenko Kateryna , Wang Liqun , Gaedicke Simone , Grosu Anca-Ligia , Firat Elke , Niedermann Gabriele
Published: April 2023

Combination of the typical T-effector cytokines TNFa and IFNg can induce tumor cell necroptosis.
Table S2 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Authors: Soni Upendra Kumar , Wang Yuhua , Pandey Ram Naresh , Roberts Ryan , Pressey Joseph G. , Hegde Rashmi S.
Published: April 2023

Reagents, instruments, tumor cell culture details
Table S1 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Authors: Soni Upendra Kumar , Wang Yuhua , Pandey Ram Naresh , Roberts Ryan , Pressey Joseph G. , Hegde Rashmi S.
Published: April 2023

Patient tumor information
Supplementary Figure S3 from Necroptosis-dependent Immunogenicity of Cisplatin: Implications for Enhancing the Radiation-induced Abscopal Effect
Authors: Luo Ren , Onyshchenko Kateryna , Wang Liqun , Gaedicke Simone , Grosu Anca-Ligia , Firat Elke , Niedermann Gabriele
Published: April 2023

RIPK3 expression in tumor cells in vitro and ex vivo and dependence of extracellular ATP on RIPK1.
Figure S5 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Authors: Soni Upendra Kumar , Wang Yuhua , Pandey Ram Naresh , Roberts Ryan , Pressey Joseph G. , Hegde Rashmi S.
Published: April 2023

Immunofluorescence images of CCH2 and NCH6 cells stained with antibodies towards IGF1R (red) and PCNA (green).
Figure S3 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
Authors: Soni Upendra Kumar , Wang Yuhua , Pandey Ram Naresh , Roberts Ryan , Pressey Joseph G. , Hegde Rashmi S.
Published: April 2023

A. Representative images for DNA fiber experiments conducted on CCH1 and CCH2 cells. In each image asterisk (*) indicates a normal fork (red-green), “N” indicates a new fork (red only), and “S” indicates a stalled fork (green only).B. Brightfield and CD99-stained (green) images of patient-derived cells used in the studies reported here.
Supplementary Figure S1 from Necroptosis-dependent Immunogenicity of Cisplatin: Implications for Enhancing the Radiation-induced Abscopal Effect
Authors: Luo Ren , Onyshchenko Kateryna , Wang Liqun , Gaedicke Simone , Grosu Anca-Ligia , Firat Elke , Niedermann Gabriele
Published: April 2023

Potency of platinum derivatives to facilitate the RT-induced abscopal effect in the B16-CD133 melanoma model.
Supplementary Tables from Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
Authors: Deng Jing , Paulus Aneel , Fang Douglas D. , Manna Alak , Wang Guangfeng , Wang Hengbang , Zhu Saijie , Chen Jianyong , Min Ping , Yin Yan , Dutta Navnita , Halder Nabanita , Ciccio Gina , Copland John A. , Miller James , Han Bing , Bai Longchuan , Liu Liu , Wang Mi , McEachern Donna , Przybranowski Sally , Yang Chao-Yie , Stuckey Jeanne A. , Wu Depei , Li Caixia , Ryan Jeremy , Letai Anthony , Ailawadhi Sikander , Yang Dajun , Wang Shaomeng , Chanan-Khan Asher , Zhai Yifan
Published: April 2023

Supplementary Tables from Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
Supplementary Figures from Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
Authors: Deng Jing , Paulus Aneel , Fang Douglas D. , Manna Alak , Wang Guangfeng , Wang Hengbang , Zhu Saijie , Chen Jianyong , Min Ping , Yin Yan , Dutta Navnita , Halder Nabanita , Ciccio Gina , Copland John A. , Miller James , Han Bing , Bai Longchuan , Liu Liu , Wang Mi , McEachern Donna , Przybranowski Sally , Yang Chao-Yie , Stuckey Jeanne A. , Wu Depei , Li Caixia , Ryan Jeremy , Letai Anthony , Ailawadhi Sikander , Yang Dajun , Wang Shaomeng , Chanan-Khan Asher , Zhai Yifan
Published: April 2023

Supplementary Figures from Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
Supplementary Data from Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
Authors: Deng Jing , Paulus Aneel , Fang Douglas D. , Manna Alak , Wang Guangfeng , Wang Hengbang , Zhu Saijie , Chen Jianyong , Min Ping , Yin Yan , Dutta Navnita , Halder Nabanita , Ciccio Gina , Copland John A. , Miller James , Han Bing , Bai Longchuan , Liu Liu , Wang Mi , McEachern Donna , Przybranowski Sally , Yang Chao-Yie , Stuckey Jeanne A. , Wu Depei , Li Caixia , Ryan Jeremy , Letai Anthony , Ailawadhi Sikander , Yang Dajun , Wang Shaomeng , Chanan-Khan Asher , Zhai Yifan
Published: April 2023

Supplementary Data from Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Authors: Bai Jiwei , Shi Jianxin , Zhang Yazhuo , Li Chuzhong , Xiong Yujia , Koka Hela , Wang Difei , Zhang Tongwu , Song Lei , Luo Wen , Zhu Bin , Hicks Belynda , Hutchinson Amy , Kirk Erin , Troester Melissa A. , Li Mingxuan , Shen Yutao , Ma Tianshun , Wang Junmei , Liu Xing , Wang Shuai , Gui Songbai , McMaster Mary L. , Chanock Stephen J. , Parry Dilys M. , Goldstein Alisa M. , Yang Xiaohong R.
Published: April 2023

Table S1. Genes included in the targeted DNA panel sequencing.
Table S2. Differences in clinical characteristics by molecular subtype.
Table S3. Distributions of mutation status in PBRM1 and SETD2 by molecular subtype in RNASeq and Nanostring datasets.
Table S4. Differentially expressed genes among molecular subtypes.
Table S5. GSEA results for up- and down-regulated gene sets comparing CC2 to CC1.
Supplementary fig 5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Authors: Bai Jiwei , Shi Jianxin , Zhang Yazhuo , Li Chuzhong , Xiong Yujia , Koka Hela , Wang Difei , Zhang Tongwu , Song Lei , Luo Wen , Zhu Bin , Hicks Belynda , Hutchinson Amy , Kirk Erin , Troester Melissa A. , Li Mingxuan , Shen Yutao , Ma Tianshun , Wang Junmei , Liu Xing , Wang Shuai , Gui Songbai , McMaster Mary L. , Chanock Stephen J. , Parry Dilys M. , Goldstein Alisa M. , Yang Xiaohong R.
Published: April 2023

Figure S5. SNAI1, SNAI3, and TWIST expression in CC1 and CC2 tumors.
Supplementary fig 4 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Authors: Bai Jiwei , Shi Jianxin , Zhang Yazhuo , Li Chuzhong , Xiong Yujia , Koka Hela , Wang Difei , Zhang Tongwu , Song Lei , Luo Wen , Zhu Bin , Hicks Belynda , Hutchinson Amy , Kirk Erin , Troester Melissa A. , Li Mingxuan , Shen Yutao , Ma Tianshun , Wang Junmei , Liu Xing , Wang Shuai , Gui Songbai , McMaster Mary L. , Chanock Stephen J. , Parry Dilys M. , Goldstein Alisa M. , Yang Xiaohong R.
Published: April 2023

Figure S4. Expression of selected markers in relation to overall survival (left) and recurrence-free survival (right) in Chinese chordoma patients with long-term follow-up data. A. CLDN11; B. GLI1; C. EPHA3; D. LEF1.
Supplementary fig 3 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Authors: Bai Jiwei , Shi Jianxin , Zhang Yazhuo , Li Chuzhong , Xiong Yujia , Koka Hela , Wang Difei , Zhang Tongwu , Song Lei , Luo Wen , Zhu Bin , Hicks Belynda , Hutchinson Amy , Kirk Erin , Troester Melissa A. , Li Mingxuan , Shen Yutao , Ma Tianshun , Wang Junmei , Liu Xing , Wang Shuai , Gui Songbai , McMaster Mary L. , Chanock Stephen J. , Parry Dilys M. , Goldstein Alisa M. , Yang Xiaohong R.
Published: April 2023

Figure S3. Gene expression profiling based on the NanoString panel in 23 skull-base (top) and 25 non-skull-base (bottom) chordoma patients from North America.
Supplementary fig 1 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
Authors: Bai Jiwei , Shi Jianxin , Zhang Yazhuo , Li Chuzhong , Xiong Yujia , Koka Hela , Wang Difei , Zhang Tongwu , Song Lei , Luo Wen , Zhu Bin , Hicks Belynda , Hutchinson Amy , Kirk Erin , Troester Melissa A. , Li Mingxuan , Shen Yutao , Ma Tianshun , Wang Junmei , Liu Xing , Wang Shuai , Gui Songbai , McMaster Mary L. , Chanock Stephen J. , Parry Dilys M. , Goldstein Alisa M. , Yang Xiaohong R.
Published: April 2023

Figure S1. A. PBRM1 and SETD2 expression between CC1 and CC2; B. PBRM1 and SETD2 expression between NCC1 and NCC2.
Supplementary Figures from LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
Authors: Melisi Davide , Ishiyama Satoshi , Sclabas Guido M. , Fleming Jason B. , Xia Qianghua , Tortora Giampaolo , Abbruzzese James L. , Chiao Paul J.
Published: April 2023

Supplementary Figures from LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
Adobe PDF - MCT-07-0337--Suppl_Materials_and_Methods.pdf from LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
Authors: Melisi Davide , Ishiyama Satoshi , Sclabas Guido M. , Fleming Jason B. , Xia Qianghua , Tortora Giampaolo , Abbruzzese James L. , Chiao Paul J.
Published: April 2023

Adobe PDF - MCT-07-0337--Suppl_Materials_and_Methods.pdf from LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
Supplementary Fig. S3 from Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells
Authors: Ko Jen-Chung , Hong Jhao-Hao , Wang Lyu-Han , Cheng Chau-Ming , Ciou Shih-Ci , Lin Szu-Ting , Jheng Ming-Yan , Lin Yun-Wei
Published: April 2023

Supplementary Fig. S3 from Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells
Supplementary Fig. S2 from Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells
Authors: Ko Jen-Chung , Hong Jhao-Hao , Wang Lyu-Han , Cheng Chau-Ming , Ciou Shih-Ci , Lin Szu-Ting , Jheng Ming-Yan , Lin Yun-Wei
Published: April 2023

Supplementary Fig. S2 from Role of repair protein Rad51 in regulating the response to gefitinib in human non-small cell lung cancer cells
Supplementary Table S2 from Anticancer effects of tanshinone I in human non-small cell lung cancer
Authors: Lee Chen-Yu , Sher Hui-Fang , Chen Huei-Wen , Liu Chun-Chi , Chen Ching-Hsien , Lin Choun-Sea , Yang Pan-Chyr , Tsay Hsin-Sheng , Chen Jeremy J.W.
Published: April 2023

Supplementary Table S2 from Anticancer effects of tanshinone I in human non-small cell lung cancer
Supplementary Table from Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays
Authors: Boyd Zachary S. , Wu Qun Jenny , O'Brien Carol , Spoerke Jill , Savage Heidi , Fielder Paul J. , Amler Lukas , Yan Yibing , Lackner Mark R.
Published: April 2023

Supplementary Table from Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays
Supplementary Table S1 from PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer
Authors: Carpinelli Patrizia , Ceruti Roberta , Giorgini Maria Laura , Cappella Paolo , Gianellini Laura , Croci Valter , Degrassi Anna , Texido Gemma , Rocchetti Maurizio , Vianello Paola , Rusconi Luisa , Storici Paola , Zugnoni Paola , Arrigoni Claudio , Soncini Chiara , Alli Cristina , Patton Veronica , Marsiglio Aurelio , Ballinari Dario , Pesenti Enrico , Fancelli Daniele , Moll Jürgen
Published: April 2023

Supplementary Table S1 from PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer
Supplementary Table S1 from Cyclooxygenase inhibitors block uterine tumorigenesis in HMGA1a transgenic mice and human xenografts
Authors: Di Cello Francescopaolo , Hillion Joelle , Kowalski Jeanne , Ronnett Brigitte M. , Aderinto Abimbola , Huso David L. , Resar Linda M.S.
Published: April 2023

Supplementary Table S1 from Cyclooxygenase inhibitors block uterine tumorigenesis in HMGA1a transgenic mice and human xenografts
Supplementary Fig. S3 from Asparagine synthetase is a predictive biomarker of l-asparaginase activity in ovarian cancer cell lines
Authors: Lorenzi Philip L. , Llamas Jenny , Gunsior Michele , Ozbun Laurent , Reinhold William C. , Varma Sudhir , Ji Helen , Kim Hijoo , Hutchinson Amy A. , Kohn Elise C. , Goldsmith Paul K. , Birrer Michael J. , Weinstein John N.
Published: April 2023

Supplementary Fig. S3 from Asparagine synthetase is a predictive biomarker of l-asparaginase activity in ovarian cancer cell lines
Supplementary Fig. S2 from Asparagine synthetase is a predictive biomarker of l-asparaginase activity in ovarian cancer cell lines
Authors: Lorenzi Philip L. , Llamas Jenny , Gunsior Michele , Ozbun Laurent , Reinhold William C. , Varma Sudhir , Ji Helen , Kim Hijoo , Hutchinson Amy A. , Kohn Elise C. , Goldsmith Paul K. , Birrer Michael J. , Weinstein John N.
Published: April 2023

Supplementary Fig. S2 from Asparagine synthetase is a predictive biomarker of l-asparaginase activity in ovarian cancer cell lines
Supplementary Fig. S1 from Asparagine synthetase is a predictive biomarker of l-asparaginase activity in ovarian cancer cell lines
Authors: Lorenzi Philip L. , Llamas Jenny , Gunsior Michele , Ozbun Laurent , Reinhold William C. , Varma Sudhir , Ji Helen , Kim Hijoo , Hutchinson Amy A. , Kohn Elise C. , Goldsmith Paul K. , Birrer Michael J. , Weinstein John N.
Published: April 2023

Supplementary Fig. S1 from Asparagine synthetase is a predictive biomarker of l-asparaginase activity in ovarian cancer cell lines
Supplementary Figure Legends from Chemopreventive and Chemotherapeutic Effects of Intravesical Silibinin against Bladder Cancer by Acting on Mitochondria
Authors: Zeng Jin , Sun Yi , Wu Kaijie , Li Lei , Zhang Gang , Yang Zenglei , Wang Zhiqiang , Zhang Dong , Xue Yan , Chen Yule , Zhu Guodong , Wang Xinyang , He Dalin
Published: April 2023

Supplementary Figure Legends from Chemopreventive and Chemotherapeutic Effects of Intravesical Silibinin against Bladder Cancer by Acting on Mitochondria
Supplementary Figure 4 from Chemopreventive and Chemotherapeutic Effects of Intravesical Silibinin against Bladder Cancer by Acting on Mitochondria
Authors: Zeng Jin , Sun Yi , Wu Kaijie , Li Lei , Zhang Gang , Yang Zenglei , Wang Zhiqiang , Zhang Dong , Xue Yan , Chen Yule , Zhu Guodong , Wang Xinyang , He Dalin
Published: April 2023

Supplementary Figure 4 from Chemopreventive and Chemotherapeutic Effects of Intravesical Silibinin against Bladder Cancer by Acting on Mitochondria
Supplementary Table S5 from Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets
Authors: Flanagan James M. , Funes Juan M. , Henderson Stephen , Wild Laurence , Carey Nessa , Boshoff Chris
Published: April 2023

Supplementary Table S5 from Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets
Supplementary Table S3 from Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets
Authors: Flanagan James M. , Funes Juan M. , Henderson Stephen , Wild Laurence , Carey Nessa , Boshoff Chris
Published: April 2023

Supplementary Table S3 from Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets
Supplementary Table S2 from Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets
Authors: Flanagan James M. , Funes Juan M. , Henderson Stephen , Wild Laurence , Carey Nessa , Boshoff Chris
Published: April 2023

Supplementary Table S2 from Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets